Table 1: Clinical and laboratory parameters in group I and group II.

Variables Group I
()
Group II
()
value

Clinical features
 Rashes20 (25)06 (17.64)0.392
 Swelling37 (46.25)08 (23.52)0.023
 Headache14 (17.50)04 (11.76)0.442
 Unconsciousness58 (72.5)25 (73.5)0.910
 Altered behavior22 (27.5)09 (26.5)0.910
 GTCS59 (73.75)23 (67.6)
 Focal seizures10 (12.5)07 (20.6)0.537
 No seizure11 (13.75)04 (11.76)
 Difficulty in breathing19 (23.75)07 (20.6)0.713
 Pallor22 (27.5)03 (8.82)0.027
 Pedal oedema37 (46.3)08 (23.52)0.023
 Signs of dehydration20 (25.0)None0.0007
 GCS score
  3–644 (55.0)15 (44.2)
  7–1019 (23.7)11 (32.4)0.529
  >1017 (21.3)08 (23.5)
 Hepatomegaly36 (45.0)18 (52.9)0.437
 Splenomegaly33 (41.25)32 (94.12)<0.001
 Tachycardia 48 (60.0)13 (38.2)0.033
 Laboratory
  investigations
 CSF cell count0.074
 6–100 68 (85)24 (70.5)
 >100 12 (15) 10 (29.5)
 SGPT raised
  (15–40 U/L)
50 (62.5) 25 (73.3)0.256
 Blood urea raised
  (20–40 mg
  per 100 mL)
55 (68.7) 04 (11.76) 0.0001
 ECG changes 20 (25) 09 (26.4)0.868
 Abnormal CT scan
  findings
6/33 03/120.613